CytoDyn (CYDY) Short Interest Ratio & Short Volume $0.12 0.00 (0.00%) (As of 11/20/2024 ET) Add Compare Share Share Short Interest Stock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest CytoDyn Short Interest DataCytoDyn (CYDY) has a short interest of 16.58 million shares. This marks a 25.78% increase in short interest from the previous month. The short interest ratio (days to cover) is 2.6, indicating that it would take 2.6 days of the average trading volume of 2.83 million shares to cover all short positions.Current Short Interest16,577,600 sharesPrevious Short Interest13,179,400 sharesChange Vs. Previous Month+25.78%Dollar Volume Sold Short$2.16 millionShort Interest Ratio2.6 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares1,219,350,000 sharesPercentage of Shares Shorted1.36%Today's Trading Volume1,858,000 sharesAverage Trading Volume2,825,476 sharesToday's Volume Vs. Average66% Short Selling CytoDyn? Sign up to receive the latest short interest report for CytoDyn and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCYDY Short Interest Over TimeCYDY Days to Cover Over TimeCYDY Percentage of Float Shorted Over Time Ad DTIMan behind OpenAI makes shocking new betBillionaire Sam Altman has become one of the most powerful men in the world by running OpenAI… But there’s a far lesser known investment he’s making that could put OpenAI to shame. In fact this Sam Altman-backed company could actually become a crucial partner for OpenAI… And the US Military… not to mention hundreds of other giant companies around the globe. To make the story even crazier… this company only recently became viable, thanks to an obscure piece of legislation that President Trump signed before he left office… Which ordered the government to take this incredible new technology seriously.Check out our report right here. CytoDyn Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/202416,577,600 shares $2.16 million +25.8%N/A2.6 $0.13 10/15/202413,179,400 shares $1.91 million +0.4%N/A2.1 $0.14 9/30/202413,133,500 shares $2.08 million +1.2%N/A3.4 $0.16 9/15/202412,982,100 shares $1.95 million +20.1%N/A2.6 $0.15 8/31/202410,806,600 shares $1.62 million +0.1%N/A3.4 $0.15 8/15/202410,797,300 shares $1.26 million +25.3%N/A1.6 $0.12 Get the Latest News and Ratings for CYDY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for CytoDyn and its competitors with MarketBeat's FREE daily newsletter. 7/31/20248,617,700 shares $1.23 million +7.4%N/A3.1 $0.14 7/15/20248,024,100 shares $1.13 million +13.5%N/A2.2 $0.14 6/30/20247,070,900 shares $982,855.10 +0.1%N/A1.8 $0.14 6/15/20247,062,000 shares $947,014.20 -12.4%N/A0.8 $0.13 5/31/20248,060,300 shares $1.27 million +72.7%N/A0.8 $0.16 5/15/20244,666,400 shares $769,956.00 +0.5%N/A2.9 $0.17 4/30/20244,643,700 shares $650,118.00 -1.4%N/A2.8 $0.14 4/15/20244,711,300 shares $683,138.50 +0.7%N/A1.5 $0.15 3/31/20244,680,600 shares $764,107.95 -8.4%N/A1.6 $0.16 3/15/20245,107,100 shares $855,439.25 -1.0%N/A0.7 $0.17 2/29/20245,159,800 shares $1.33 million +9.2%N/A0.7 $0.26 2/15/20244,724,300 shares $798,595.67 -25.2%N/A0.8 $0.17 1/15/202410,691,100 shares $2.24 million -1.9%N/A3.1 $0.21 12/31/202310,893,600 shares $2.12 million +0.3%N/A1.8 $0.20 12/15/202310,863,000 shares $3.07 million -16.2%N/A1.2 $0.28 11/30/202312,960,200 shares $2.22 million 0.0%N/A2.6 $0.17 11/15/202312,965,900 shares $2.20 million -0.9%N/A6.7 $0.17 10/31/202313,087,700 shares $2.05 million +0.2%N/A5 $0.16 10/15/202313,058,200 shares $2.25 million -11.3%N/A7.5 $0.17 9/30/202314,723,600 shares $2.73 million -0.4%N/A8.3 $0.19 9/15/202314,785,400 shares $2.81 million +0.1%N/A9.2 $0.19 8/31/202314,770,500 shares $3.12 million -8.1%N/A8.6 $0.21 8/15/202316,067,600 shares $3.58 million -40.0%N/A2.2 $0.22 7/31/202326,765,000 shares $5.59 million +0.3%N/A7.8 $0.21 7/15/202326,695,600 shares $6.96 million -0.1%N/A10.5 $0.26 6/30/202326,722,500 shares $7.22 million -0.8%N/A11.1 $0.27 6/15/202326,948,200 shares $6.79 million -0.2%N/A9.9 $0.25 5/31/202327,009,000 shares $7.07 million -3.3%N/A14.2 $0.26 5/15/202327,921,000 shares $7.40 million +1.7%N/A13.9 $0.27 4/30/202327,460,800 shares $8.04 million -1.8%N/A18.5 $0.29 4/15/202327,965,300 shares $8.45 million +3.2%N/A6.7 $0.30 3/31/202327,096,500 shares $9.75 million +1.4%N/A11.2 $0.36 3/15/202326,726,800 shares $10.00 million +2.4%N/A5.6 $0.37 2/28/202326,113,800 shares $8.38 million +2.7%N/A7.2 $0.32Breaking News: Tesla headed to $500… (Ad)That headline hit late last night…and the rally has begun Which is why we want to urge you to go ahead and download Lance’s e-Book now outlining his bullish case for Tesla. So to claim your free digital copy today, simply follow this link and enter your email address. 2/15/202325,428,900 shares $7.08 million -2.7%N/A6.8 $0.28 1/31/202326,140,000 shares $6.88 million -1.5%N/A6.9 $0.26 1/15/202326,528,000 shares $6.63 million -4.1%N/A6.7 $0.25 12/30/202227,656,900 shares $6.22 million -11.7%N/A2.7 $0.23 12/15/202231,304,500 shares $10.02 million -4.6%N/A10.7 $0.32 11/30/202232,811,200 shares $11.81 million -3.3%N/A13.5 $0.36 11/15/202233,929,800 shares $13.40 million -5.0%N/A16.1 $0.40 10/31/202235,699,900 shares $12.25 million -5.1%N/A17.8 $0.34 10/15/202237,621,300 shares $16.55 million -5.9%N/A16.9 $0.44 9/30/202239,993,600 shares $16.60 million +0.7%N/A11.8 $0.42 9/15/202239,705,000 shares $24.02 million -2.1%N/A23.3 $0.61 8/31/202240,549,900 shares $21.15 million -8.8%N/A11.2 $0.52 8/15/202244,456,900 shares $36.79 million -11.7%N/A4.8 $0.83 7/31/202250,345,200 shares $38.77 million -3.5%N/A5.8 $0.77 7/15/202252,176,600 shares $22.95 million -2.1%N/A13.2 $0.44 6/30/202253,281,600 shares $22.37 million +2.4%N/A32.8 $0.42 6/15/202252,028,700 shares $20.65 million +4.6%N/A12.6 $0.40 5/31/202249,725,000 shares $15.96 million +6.3%N/A19.8 $0.32 5/15/202246,788,400 shares $15.91 million +1.6%N/A16.1 $0.34 4/30/202246,043,000 shares $14.69 million +15.1%N/A7.5 $0.32 4/15/202239,997,200 shares $10.60 million -10.4%N/A7.2 $0.27 3/31/202244,660,400 shares $16.41 million +1.0%N/A6.9 $0.37 3/15/202244,227,800 shares $17.03 million +1.1%N/A14 $0.39 2/28/202243,739,200 shares $22.39 million +3.7%N/A10 $0.51 2/15/202242,170,100 shares $24.42 million +0.5%N/A9.9 $0.58 1/31/202241,945,600 shares $22.23 million +4.6%N/A5.9 $0.53 1/15/202240,088,600 shares $27.86 million +25.5%N/A3 $0.70 12/31/202131,937,600 shares $31.58 million -1.4%N/A6.1 $0.99 12/15/202132,391,100 shares $33.52 million +5.5%N/A6.2 $1.04 11/30/202130,702,100 shares $38.38 million +0.6%N/A8.1 $1.25 11/15/202130,529,000 shares $37.70 million -7.0%N/A5.1 $1.24 10/29/202132,828,700 shares $41.04 million -7.2%N/A6.6 $1.25 10/15/202135,369,200 shares $50.22 million -9.8%N/A8.5 $1.42 9/30/202139,207,900 shares $77.63 million +2.2%N/A7.1 $1.98 9/15/202138,362,800 shares $58.50 million +2.4%N/A9.1 $1.53 8/31/202137,467,600 shares $51.71 million +2.4%N/A11.4 $1.38 8/13/202136,577,500 shares $53.95 million +1.4%N/A6.9 $1.48 7/30/202136,063,100 shares $60.95 million +2.9%N/A8.7 $1.69 7/15/202135,060,100 shares $47.93 million -2.0%N/A8.5 $1.37 6/30/202135,769,200 shares $60.81 million -4.2%N/A9.5 $1.70 6/15/202137,327,400 shares $66.44 million -4.8%N/A8.3 $1.78 5/28/202139,220,400 shares $74.52 million +4.7%N/A4.8 $1.90 5/14/202137,454,600 shares $98.13 million +0.1%N/A10 $2.62 4/30/202137,406,300 shares $104.36 million -1.4%N/A12.5 $2.79 4/15/202137,949,100 shares $108.15 million +7.3%N/A5 $2.85 3/31/202135,355,800 shares $99.70 million +11.3%N/A9.5 $2.82 3/15/202131,756,800 shares $72.61 million +38.8%N/A2.2 $2.29 2/26/202122,887,200 shares $108.03 million +5.9%N/A3.3 $4.72 2/12/202121,610,000 shares $119.72 million -21.8%N/A2.2 $5.54 1/29/202127,620,400 shares $140.86 million -8.5%N/A5.2 $5.10Breaking News: Tesla headed to $500… (Ad)That headline hit late last night…and the rally has begun Which is why we want to urge you to go ahead and download Lance’s e-Book now outlining his bullish case for Tesla. So to claim your free digital copy today, simply follow this link and enter your email address. 1/15/202127,043,500 shares $142.95 million +0.9%N/A3.9 $5.29 12/31/202028,551,500 shares $141.47 million +5.6%N/A1.7 $4.96 12/15/202027,043,500 shares $88.97 million +0.9%N/A3.9 $3.29 11/30/202026,802,300 shares $71.29 million -0.1%N/A8.5 $2.66 11/15/202026,829,000 shares $66.54 million +0.5%N/A4.1 $2.48 10/30/202026,696,700 shares $63.81 million +9.7%N/A4.7 $2.39 10/15/202024,327,000 shares $69.58 million +4.2%N/A4.6 $2.86 9/30/202023,357,800 shares $68.20 million -1.3%N/A5.4 $2.92 9/15/202023,659,300 shares $96.77 million -10.8%N/A3.3 $4.09 8/31/202026,536,800 shares $89.16 million +42.2%N/A2.3 $3.36 8/14/202018,666,200 shares $70.18 million +41.0%N/A2.3 $3.76 7/31/202013,240,400 shares $65.86 million +38.2%N/A1.2 $4.97 7/15/20209,577,900 shares $46.45 million -6.6%N/A0.5 $4.85 6/30/202010,252,400 shares $89.91 million +11.1%N/A0.7 $8.77 6/15/20209,230,700 shares $28.52 million -6.4%N/A1.9 $3.09 5/29/20209,858,200 shares $27.80 million +3.4%N/A1.5 $2.82 5/15/20209,536,700 shares $28.61 million +10.3%N/A0.9 $3.00 4/30/20208,650,000 shares $28.07 million +6.5%N/A0.7 $3.25 4/15/20208,119,200 shares $20.38 million +11.4%N/A0.4 $2.51 3/31/20207,287,900 shares $23.18 million +34.0%N/A1.3 $3.18 3/13/20205,440,900 shares $15.67 million -10.8%N/A1.4 $2.88 2/28/20206,100,100 shares $6.10 million -3.3%N/A1.4 $1.00 2/14/20206,311,200 shares $6.50 million +15.8%N/A0.5 $1.03 1/31/20205,451,900 shares $5.94 million +49.5%N/A1.2 $1.09 1/15/20203,647,100 shares $4.38 million +34.1%N/A0.7 $1.20 12/31/20192,720,300 shares $2.97 million +2,191.7%N/A0.4 $1.09 CYDY Short Interest - Frequently Asked Questions What is CytoDyn's current short interest? Short interest is the volume of CytoDyn shares that have been sold short but have not yet been covered or closed out. As of October 31st, traders have sold 16,577,600 shares of CYDY short. Learn More on CytoDyn's current short interest. What is a good short interest ratio for CytoDyn? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CYDY shares currently have a short interest ratio of 3.0. Learn More on CytoDyn's short interest ratio. Is CytoDyn's short interest increasing or decreasing? CytoDyn saw a increase in short interest in the month of October. As of October 31st, there was short interest totaling 16,577,600 shares, an increase of 25.8% from the previous total of 13,179,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does CytoDyn's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to CytoDyn: Annexon, Inc. (7.29%), ChromaDex Co. (5.39%), IGM Biosciences, Inc. (16.29%), ABIVAX Société Anonyme (0.35%), Humacyte, Inc. (17.63%), Astria Therapeutics, Inc. (7.47%), Organogenesis Holdings Inc. (12.59%), Corvus Pharmaceuticals, Inc. (4.56%), Altimmune, Inc. (32.26%), Sana Biotechnology, Inc. (28.18%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short CytoDyn stock? Short selling CYDY is an investing strategy that aims to generate trading profit from CytoDyn as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against CytoDyn? A short squeeze for CytoDyn occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CYDY, which in turn drives the price of the stock up even further. How often is CytoDyn's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CYDY, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies CRVS Short Interest ABVX Short Interest ATXS Short Interest IGMS Short Interest ORGO Short Interest SANA Short Interest GLUE Short Interest GHRS Short Interest PRTC Short Interest PROK Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:CYDY) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CytoDyn Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CytoDyn With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
